ConKay Medical Systems is an early stage medical device company that develops solutions to treat valvular regurgitation in patients with progressive heart failure.

ConKay Medical Systems

ConKay Medical Systems is an early-stage medical device company advancing unique solutions to treat valvular regurgitation in patients with progressive heart failure.   Valvular regurgitation is when your valves do not close properly allowing blood to flow backwards in your heart causing shortness of breath, chest pain, and sometimes death.  There are over 100 million people currently affected globally with valvular disease and an additional 5M Americans are diagnosed each year. ConKay’s annular repair technology is designed to treat the main cause of functional regurgitation leaving the healthy leaflets intact to perform the way it was intended.  We are currently focused on the Tricuspid valve.  Message us for more information!

ConKay Medical Systems, Inc.

Welcome, Yvette Ramirez!

We are thrilled to announce that Yvette Ramirez is joining ConKay Medical as our new Sr. R&D Engineer. Yvette brings a passion for innovation that aligns perfectly with our mission to advance ConKay's unique annular valve repair technology for Tricuspid Regurgitation.

Yvette has spent the last several years with Medtronic Structural Heart as a Research and Development Engineer working on transcatheter aortic heart valve replacements. During this time, she has led work packages on next-generation programs, contributed to successful global market expansions, and supported new product launches.

We are super excited to have her on board and look forward to the incredible contributions she will bring to our team.

Please join us in giving Yvette a warm welcome!

#ConKayMedicalSystems #NewHire #WelcometotheTeam

Thrilled to share that ConKay Medical Systems, Inc. has been featured in an article by MedTech World!  #HealthTech #Innovation #ValvularRegurgitation #TricuspidRegurgitation #Gratitude"

Wishing all our friends a holiday season filled with joy and laughter!

ConKay Medical Systems, Inc. is excited to announce that we have closed an oversubscribed seed financing round!  

https://lnkd.in/esYPTqjF

A special thank you to the MedTech Startup team for having ConKay Medical Systems, Inc. on your podcast.  We are thrilled to continue supporting the incredible work you do in shedding light on entrepreneurs and amplifying the voices within the Medtech community.  

To see the full episode, the link is: https://lnkd.in/gMEDNMPG

Special Mentions:
UCSF Rosenman Institute , MedTech Innovator , Paul Grand , Christine Winoto, Peter K. Johansson, P.E., Virginia Giddings, Brian Lowry

February is Heart Month, and today marks Heart Valve Disease Awareness Day! At ConKay Medical Systems, Inc., we're passionate about making a difference in the lives of patients worldwide.

💡 Did you know that there are millions of patients worldwide that suffer from Valvular Regurgitation or leaking heart valves?  While we have the potential to treat every valve in the heart, we are currently focused on the Tricuspid valve where many patients are often left with no medical options. That's why we're dedicated to developing innovative medical devices that could change the game for these patients.
🌟 Our goal is simple: to extend lives and improve quality of life for those battling heart valve disease, enabling them to cherish more moments with their loved ones.

Let's raise awareness and support those affected by heart valve disease this month and beyond! #HeartMonth #ValveDiseaseAwareness #ConKayMedicalSystems

Metric
Company Name	ConKay Medical Systems
Symbol
MSH ID	COM:CONKAYMEDICAL
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	US
Stage
Employee Count	3
Website	conkaymedical.com
LinkedIn	conkay-medical-systems-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CONKAYMEDICAL

ConKay Medical Systems

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue